DiaMedica Therapeutics Inc.

DMAC · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.3B · 35 employees
136
SEC Filings
$10.77
Close 2026-11-04
35
Employees

Business Summary

DiaMedica Therapeutics is a clinical-stage biopharmaceutical company developing DM199 (rinvecalinase alfa), a recombinant human tissue kallikrein-1 (rhKLK1) protein, for the treatment of preeclampsia (PE), fetal growth restriction (FGR), and acute ischemic stroke (AIS). DM199 has received FDA Fast Track Designation for AIS. The company also holds a patent for DM300, a recombinant human ulinastatin targeting severe acute pancreatitis. Clinical trials are ongoing in South Africa, North America, and globally.

Latest Stock Quote

DMAC 2026-11-04 $10.77 O:$10.15 H:$11 L:$10.15 Vol:0.4M VWAP:$10.7025
origin leaf: null

Next Earnings

expected 2027-02-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001437749-26-010342EDGAR77K words
2025-03-172024-12-310001437749-25-008018EDGAR77K words
2024-03-192023-12-310001437749-24-008522EDGAR70K words
2023-03-282022-12-310001437749-23-008189EDGAR77K words
2022-03-142021-12-310001437749-22-006163EDGAR71K words
2021-03-102020-12-310001437749-21-005541EDGAR67K words
2020-03-232019-12-310001437749-20-005906EDGAR74K words
2019-03-192018-12-310001437749-19-005272EDGAR63K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-122026-09-300001437749-26-036602EDGAR19K words
2026-08-102026-06-300001437749-26-026792EDGAR17K words
2025-11-122025-09-300001437749-25-034469EDGAR19K words
2025-08-122025-06-300001437749-25-026207EDGAR18K words
2025-05-132025-03-310001437749-25-016488EDGAR15K words
2024-11-132024-09-300001437749-24-034925EDGAR17K words
2024-08-072024-06-300001437749-24-025198EDGAR17K words
2024-05-082024-03-310001437749-24-015381EDGAR13K words
2023-11-132023-09-300001437749-23-031671EDGAR18K words
2023-08-142023-06-300001437749-23-023708EDGAR17K words
2023-05-152023-03-310001437749-23-014616EDGAR16K words
2022-11-092022-09-300001437749-22-026609EDGAR18K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-120001437749-26-036600EDGAR5K words
2026-08-100001437749-26-026790EDGAR5K words
2026-03-310001437749-26-010409EDGAR4K words
2026-01-050001437749-26-000175EDGAR0K words
2025-12-180001437749-25-038211EDGAR1K words
2025-11-120001437749-25-034467EDGAR4K words
2025-08-120001437749-25-026286EDGAR1K words
2025-08-120001437749-25-026205EDGAR4K words
2025-08-060001437749-25-024956EDGAR3K words
2025-07-210001437749-25-023048EDGAR22K words

136 total filings indexed. 106 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

preeclampsia-and-fetal-growth-restriction acute-ischemic-stroke severe-acute-pancreatitis ischemic-disease fda-fast-track-designation adaptive-design-clinical-trial-(phase-2/3) recombinant-protein-(rhklk1)

Company Identity

CIK0001401040
TickerDMAC
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedZ4
Websitehttps://www.diamedica.com
Listed2007-11-29

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: eabb4362eb845d89aba806f9c5fe011f4c3bde5df046857c5caf71b6b527cf60
parent: f526ce2d6a21576e6d1e576f55a0a5b83875c37388107d893debf0cfd2502b39
content hash: 95cf6140dc4428497428f12bab67fb5180d153459ccf317e31f0718cec6a8240
signed: 2026-11-16T19:01:42.232Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up DMAC using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on DMAC, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/DMAC (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.